Overall rank by patents
#27,560
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
TARO Pharmaceutical Industries Ltd.
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
10
Total patents granted
6
CPC technology areas
19.1
Avg claims per patent
+133%
5-year filing velocity
The verdict
TARO holds 10 US patents across 6 technology areas, rank #27,560 of 50,000 tracked assignees.
- #27,560
- of 50,000 US assignees by volume
- Top 32%
- by Innovation Score (41.7/100)
- 19.1
- avg claims per patent
- +133%
- filing velocity, last 5 yrs
Portfolio overview
TARO Pharmaceutical Industries Ltd. has been granted 10 US utility patents between 2016 and 2025, placing TARO Pharmaceutical Industries Ltd. at rank #27,560 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, TARO Pharmaceutical Industries Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, TARO sits between Tannpapier Gmbh (10 patents, rank #27,556) and TCR2 Therapeutics Inc. (10 patents, rank #27,564) - the closest US assignees by grant volume. The composite Innovation Score of 41.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 3 in the 2015–2019 window, a +133% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. TARO Pharmaceutical Industries Ltd.'s 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark TARO Pharmaceutical Industries Ltd. against peers pursuing similar technology classes.
Who files at TARO's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Tannpapier
TANNPAPIER GMBH
10 patents
- TAO Clean
TAO Clean, LLC
10 patents
- Tapcentive
TAPCENTIVE, INC.
10 patents
- Taplast s r l
TAPLAST s.r.l.
10 patents
- TATE & LYLE Techn…
TATE & LYLE TECHNOLOGY LIMITED
10 patents
- TAU Orthopedics
TAU ORTHOPEDICS, INC.
10 patents
- Tazmo
TAZMO CO., LTD.
10 patents
- TCR2 Therapeutics
TCR2 THERAPEUTICS INC.
10 patents
- TARO Pharmaceutic… ◀
TARO PHARMACEUTICAL INDUSTRIES LTD.
10 patents
What this shows TARO holds 10 patents at rank #27,560, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near TARO
By rank, the assignees closest to #27,560 in granted patent volume.
- Tannpapier Gmbh #27,556 · 10 patents
- TAO Clean, Llc #27,557 · 10 patents
- Tapcentive, Inc. #27,558 · 10 patents
- Taplast S.r.l. #27,559 · 10 patents
- TATE & LYLE Technology Limited #27,561 · 10 patents
- TAU Orthopedics, Inc. #27,562 · 10 patents
- Tazmo Co., Ltd. #27,563 · 10 patents
- TCR2 Therapeutics Inc. #27,564 · 10 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in TARO's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
TARO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2018 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2023 | 4 | 40.0% |
| 2025 | 1 | 10.0% |
Which technologies does TARO Pharmaceutical Industries Ltd. patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does TARO Pharmaceutical Industries Ltd. hold?
TARO Pharmaceutical Industries Ltd. holds 10 US granted patents filed between 2016 and 2025, spanning 6 technology areas.
What is TARO Pharmaceutical Industries Ltd.'s Innovation Score?
TARO Pharmaceutical Industries Ltd. has an Innovation Score of 41.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does TARO Pharmaceutical Industries Ltd. focus on?
TARO Pharmaceutical Industries Ltd.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 6 patents. The company has filed patents in 6 CPC subclasses total.
Is TARO Pharmaceutical Industries Ltd.'s patent filing rate increasing or decreasing?
TARO Pharmaceutical Industries Ltd.'s recent filing velocity is +133% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for TARO Pharmaceutical Industries Ltd.'s patents?
TARO Pharmaceutical Industries Ltd.'s patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the TARO Pharmaceutical Industries Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
TARO's 10 grants land it in the top 32% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - TARO ranks #27,560 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.